Mammoth Biosciences - StartupWiki | AI Startup Research Directory

StartupWiki - AI-Powered Startup Research DirectoryStartupWiki is a community-driven AI-powered research directory of global startup ventures. Explore in-depth profiles of AI, Biotech, CleanTech, FinTech, Cybersecurity, and other deep-tech startups with funding data, financial metrics, competitive analysis, and team insights.Browse categories: AI & Machine Learning, FinTech, Biotech, Cybersecurity, CleanTech, Quantum Computing, and more.Read our blog for startup insights and deep dives.

Mammoth Biosciences — Startup ProfileCRISPR platform company developing diagnostics and therapeuticsHQ: Brisbane, CA, USA | Founded: 2017 | Employees: 100+ | Stage: Late Stage VC | Website: https://mammoth.bioAboutMammoth Biosciences harnesses the diversity of nature to discover and develop novel CRISPR systems, building a platform that spans both diagnostics and therapeutics. The company's approach enables it to read and write the code of life across multiple verticals, including point-of-care molecular diagnostics and in vivo gene editing. Founded with close ties to CRISPR pioneer Jennifer Doudna, Mammoth has raised over $218M in venture funding and reached unicorn status in 2021.Key Metrics

Latest Valuation: $1B+

Last Round: $150M Series D

Total Funding: $218M+

Headcount: 100+

Founded: 2017

Est. Runway: 430 months (est.)

Funding Rounds

Round: $23M (2018-01-01) — Undisclosed

Round: $45M (2020-01-30) — Undisclosed

Round: $150M (2021-09-09) — Redmile Group

Key People

Trevor Martin

Jennifer Doudna

Key Competitors

Sherlock Biosciences —

Editas Medicine —

Intellia Therapeutics —

Broad Institute / CRISPR Therapeutics —

Timeline Highlights

2021-09-09: Series D / Unicorn

2020-01-30: Series B

2018-01-01: Series A

2017-01-01: Company Founded